I-gel Versus Classic-Laryngeal Mask Airway (C-LMA) as a Conduit for Tracheal Intubation Using Ventilating Bougie

July 26, 2018 updated by: DR ADITI AMRUTLAL DHIMAR, Medical College Baroda

I-gel Versus C-LMA as a Conduit for Tracheal Intubation Using Ventilating Bougie

Supraglottic Airway devices(SGAs) like I-Gel and C-LMA ( classic laryngeal mask airway ) have been used as a conduit for tracheal intubation using ventilating bougie. General Anaesthesia with tracheal intubation is one of the technique for giving anaesthesia. Tracheal intubation may become difficult sometimes and endangers patients life. Using SGAs as a conduit for tracheal intubation helps in securing airway. This will be further facilitated by using ventilating bougie, as it maintains oxygenation.

Study Overview

Detailed Description

SGAs have been used as a conduit for tracheal intubation using ventilating bougie. Patients were anaesthetised with intravenous induction agent, non-depolarising muscle relaxant and then SGAs were inserted. Two groups were compared. In group I : I-gel was inserted, its position was confirmed and then ventilating bougie was inserted through it. It's position was confirmed, then I-gel was removed , Endotracheal tube was railroaded over ventilating bougie and it's position was confirmed. In group C : C-LMA was inserted, its position was confirmed and then ventilating bougie was inserted through it. It's position was confirmed, then C-LMA was removed , Endotracheal tube was railroaded over ventilating bougie and it's position was confirmed.

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 18 to 60 years
  • Gender : either sex
  • American society of Anaesthesiologist's Physical Status (ASAPS) I and II
  • Patients posted for surgery requiring general anaesthesia and endotracheal intubation.

Exclusion Criteria:

  • age <18 years and > 60 years
  • ASAPS III or IV
  • Obesity body mass index >25
  • Patients with mouth opening <2cms
  • Patients with Malampatti grade III and IV
  • Patients having history of gastro-esophageal reflux disease
  • Patients with history of inadequate fasting
  • Patients with known or anticipated difficult tracheal intubation or face-mask ventilation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Group-I
Tracheal intubation using I-gel and ventilating bougie insertion. In Group-I, following general anaesthesia I-gel is to be inserted, through it ventilating bougie is to be inserted then I-gel is to be removed and endotracheal tube is to be railroaded over ventilating bougie. Then ventilating bougie is to be removed.
Following general anaesthesia I-gel was inserted. After proper placement . ventilating bougie was inserted. Once it's placement is confirmed I-gel was removed keeping the ventilating bougie in situ. Then appropriate sized endotracheal tube was railroaded over ventilating bougie then it (v.bouggie) was removed . Proper placement of endotracheal tube was confirmed by bilateral equal chest excursion and air entry on auscultation, absence of gastric insuffflation sound over epigastrium and 'sine' wave on capnography. Maximum 3 attempts were allowed for I-gel, ventilating bougie and endotracheal tube.
ACTIVE_COMPARATOR: Group-C
Tracheal intubation using C-LMA and ventilating bougie insertion. In Group-C, following general anaesthesia C-LMA is to be inserted, through it ventilating bougie is to be inserted then C-LMA is to be removed and endotracheal tube is to be railroaded over ventilating bougie. Then ventilating bougie is to be removed.
Following general anaesthesia C-LMA was inserted. After proper placement of C-LMA, ventilating bougie was inserted. It's placement was confirmed and C-LMA was removed after deflation of cuff keeping the ventilating bougie in situ. Then appropriate sized endotracheal tube was railroaded over ventilating bougie. It's placement was confirmed by bilateral equal air entry and chest excursion, absence of gastric insufflation sound over epigastrium and 'sine' wave on capnography. Maximum 3 attempts were allowed for C-LMA , ventilating bougie and endotracheal tube.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Attempts for I-gel or Classic-LMA Insertions
Time Frame: 60 seconds
60 seconds
Number of Attempts for Ventilating Bougie Insertions Through I-gel or C-LMA
Time Frame: 45 seconds
45 seconds
Number of Attempts for Railroading of Endotracheal Tube Over Ventilating Bougie
Time Frame: 30 seconds
30 seconds
Time of Insertion
Time Frame: 5 minutes
5 minutes
Total Intubation Time
Time Frame: 5 minutes
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: 25 minutes

Heart rate to observe at the following time intervals.

  1. Base line
  2. After induction
  3. After dexmedetomidine injection
  4. Supraglottic airway insertion
  5. Ventilating bougie insertion
  6. ETT insertion
  7. 3minute after ETT insertion
  8. 5 minute after ETT insertion
  9. 7 minute after ETT insertion
  10. 10 minute after ETT insertion
  11. 15 minute after ETT insertion Study period is upto 15 minutes, thereafter the study ends here.
25 minutes
Systolic Blood Pressure
Time Frame: 25 minutes

Systolic blood pressure measured at following time intervals.

  1. Base line
  2. After Dexmedetomidine injection
  3. After induction of anaesthesia
  4. Supraglottic airway insertion
  5. Ventilating bougie insertion
  6. ETT insertion
  7. 3 minute after ETT insertion
  8. 5 minute after ETT insertion
  9. 7 minute after ETT insertion
  10. 10 minute after ETT insertion
  11. 15 minute after ETT insertion. The study period was upto 15 minutes and thereafter the study ends.
25 minutes
Diastolic Blood Pressure
Time Frame: 25 minutes

Diastolic blood pressure measured at following time intervals.

  1. Base line
  2. After Dexmedetomidine injection
  3. After Induction
  4. Supraglottic airway insertion
  5. Ventilating bougie insertion
  6. ETT insertion
  7. 3 minute after ETT insertion
  8. 5 minute after ETT insertion
  9. 7 minute after ETT insertion
  10. 10 minutes after ETT insertion
  11. 15 minute after ETT insertion The study period was upto 15 minutes. thereafter study ends.
25 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aditi A Dhimar, M.D.(anaes), CDSCO

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (ACTUAL)

January 1, 2015

Study Completion (ACTUAL)

February 1, 2015

Study Registration Dates

First Submitted

September 7, 2015

First Submitted That Met QC Criteria

September 30, 2015

First Posted (ESTIMATE)

October 2, 2015

Study Record Updates

Last Update Posted (ACTUAL)

July 27, 2018

Last Update Submitted That Met QC Criteria

July 26, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • ECR/85/Inst/GJ/2013

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation; Difficult

Clinical Trials on Tracheal Intubation using I-gel and ventilating bougie

Subscribe